London Daily

Focus on the big picture.
Monday, Jul 14, 2025

Inventor of the world’s most promising coronavirus vaccine says his drug can end the pandemic

Inventor of the world’s most promising coronavirus vaccine says his drug can end the pandemic

The scientist behind the promising Pfizer coronavirus vaccine with more than 90% efficacy says the drug can end the pandemic. BioNTech CEO Uğur Şahin explained in an interview that the vaccine protection from symptomatic infections “will have a dramatic effect” on the health crisis. Several experts already explained that completely eradicating COVID-19 seems unlikely, but vaccines will help end the pandemic and turn the novel coronavirus into an endemic illness, like the flu.
Pfizer may be getting all the glory in the US. But the coronavirus vaccine that the company announced is more than 90% effective against the pathogen wasn’t actually created by Pfizer. A German company called BioNTec developed the mRNA vaccine, which was a first for the industry when it was developed.

And now that the BioNTech drug showed incredible efficacy according to interim data, BioNTech CEO Uğur Şahin thinks that the drug has the potential to end the pandemic.SARS-CoV-2 is the virus that causes COVID-19, and it isn’t likely to go away anytime soon. The idea of eradicating it is only theoretical.

That’s something we heard time and again from experts in the field, including Dr. Anthony Fauci and World Health Organization officials. Factors like the virus’s infectivity, mutations, the unknown efficacy of vaccines, the phased rollouts of vaccines, the major logistical hurdles, the public resistance to immunization, and limited coronavirus immunity make eradication practically impossible.

And if the world ever reaches that point, it will take many years until vaccines are improved and enough people get COVID-19 shots routinely. But eradication isn’t necessary in order to end the pandemic — and Şahin says the Pfizer/BioNTech drug can help the world do just that.

“If the question is whether we can stop this pandemic with this vaccine, then my answer is: yes, because I believe that even protection only from symptomatic infections will have a dramatic effect,” Şahin told The Guardian in an interview.

The scientist said that he wasn’t sure until Monday whether the vaccine would trigger a strong enough reaction. “It was possible that the virus isn’t really targeted by the vaccine, finds its way into the cells, and continues to make people ill. We now know that vaccines can beat this virus.”

Once the full data from Pfizer’s Phase 3 trial is available, the two companies will have better results that include a final efficacy rate. Not all questions will be answered immediately, however. The companies might need up to a year to determine whether the vaccine can stop asymptomatic infections or even effectively block the infection. Şahin explained that once the virus reaches the body, it works “in more ways than one.”

“The vaccine hinders Covid-19 from gaining access to our cells. But even if the virus manages to find a way in, then the T-cells bash it over the head and eliminate it,” he said. “We have trained the immune system very well to perfect these two defensive moves. We now know that the virus can’t defend itself against these mechanisms.”

Even if an infection occurs, the vaccine would raise a faster response and patients should be less likely to develop severe symptoms. That’s the goal of the first wave of vaccines, according to Dr. Fauci.

The German scientist also tacked the speed of development for mRNA vaccines. The fact that the method uses genetic code from the virus has shortened the production process by almost three months. Pfizer’s involvement brought in expertise and resources that further streamlined the development process, reducing it to 10 months instead of years. “There was practically no waiting time,” he said. “Imagine you want to get from one end of London to the next, and there are traffic jams everywhere. You would need half a day. For our project, the streets were empty.”

Şahin also dispelled notions that Pfizer and BioNTech withheld vaccine data from the American public and waited to release it until after the presidential election, something President Trump claimed on Twitter earlier this week. He said he found out the news from Pfizer CEO Albert Bourla on Monday, one day before the companies announced it to the world. Bourla himself received the interim results a few minutes before calling Şahin in Germany.

As for coronavirus immunity, the BioNTech CEO said he hops vaccinated people will be immune from the illness for at least a year, although it’s still too early to draw any real conclusions. “We only have indirect clues so far [regarding the duration of immunity],” he said. “Studies of Covid-19 patients have shown that those with a strong immune response still have that response after six months. I could imagine we could be safe for at least a year.” The expert also acknowledged that people might need to “top up” with annual vaccines.

Pfizer and BioNTech are only two of the hundreds of teams developing coronavirus vaccines. The more drugs that are approved, the easier it will be for more countries to get access to them — and the sooner the pandemic will end. When enough people get vaccinated with whatever drugs regulators approve, and enough people develop immunity after infection or immunization, health officials will declare the pandemic over. Once that happens, COVID-19 will probably become endemic and far less deadly, just like the flu.
Newsletter

Related Articles

0:00
0:00
Close
Bal des Pompiers: A Celebration of Community and Firefighter Culture in France
FBI Chief Kash Patel Denies Resignation Speculations Amid Epstein List Controversy
Air India Pilot’s Mental Health Records Under Scrutiny
Google Secures Windsurf AI Coding Team in $2.4 Billion Licence Deal
Jamie Dimon Warns Europe Is Losing Global Competitiveness and Flags Market Complacency
South African Police Minister Suspended Amid Organised Crime Allegations
Nvidia CEO Claims Chinese Military Reluctance to Use US AI Technology
Hong Kong Advances Digital Asset Strategy to Address Economic Challenges
Australia Rules Out Pre‑commitment of Troops, Reinforces Defence Posture Amid US‑China Tensions
Martha Wells Says Humanity Still Far from True Artificial Intelligence
Nvidia Becomes World’s First Four‑Trillion‑Dollar Company Amid AI Boom
U.S. Resumes Deportations to Third Countries After Supreme Court Ruling
Excavation Begins at Site of Mass Grave for Children at Former Irish Institution
Iranian President Reportedly Injured During Israeli Strike on Secret Facility
EU Delays Retaliatory Tariffs Amid New U.S. Threats on Imports
Trump Defends Attorney General Pam Bondi Amid Epstein Memo Backlash
Renault Shares Drop as CEO Luca de Meo Announces Departure Amid Reports of Move to Kering
Senior Aides for King Charles and Prince Harry Hold Secret Peace Summit
Anti‑Semitism ‘Normalised’ in Middle‑Class Britain, Says Commission Co‑Chair
King Charles Meets David Beckham at Chelsea Flower Show
If the Department is Really About Justice: Ghislaine Maxwell Should Be Freed Now
NYC Candidate Zohran Mamdani’s ‘Antifada’ Remarks Spark National Debate on Political Language and Economic Policy
President Trump Visits Flood-Ravaged Texas, Praises Community Strength and First Responders
From Mystery to Meltdown, Crisis Within the Trump Administration: Epstein Files Ignite A Deepening Rift at the Highest Levels of Government Reveals Chaos, Leaks, and Growing MAGA Backlash
Trump Slams Putin Over War Death Toll, Teases Major Russia Announcement
Reparations argument crushed
Rainmaker CEO Says Cloud Seeding Paused Before Deadly Texas Floods
A 92-year-old woman, who felt she doesn't belong in a nursing home, escaped the death-camp by climbing a gate nearly 8 ft tall
French Journalist Acquitted in Controversial Case Involving Brigitte Macron
Elon Musk’s xAI Targets $200 Billion Valuation in New Fundraising Round
Kraft Heinz Considers Splitting Off Grocery Division Amid Strategic Review
Trump Proposes Supplying Arms to Ukraine Through NATO Allies
EU Proposes New Tax on Large Companies to Boost Budget
Trump Imposes 35% Tariffs on Canadian Imports Amid Trade Tensions
Junior Doctors in the UK Prepare for Five-Day Strike Over Pay Disputes
US Opens First Rare Earth Mine in Over 70 Years in Wyoming
Kurdistan Workers Party Takes Symbolic Step Towards Peace in Northern Iraq
Bitcoin Reaches New Milestone of $116,000
Biden’s Doctor Pleads the Fifth to Avoid Self-Incrimination on President’s Medical Fitness
Grok Chatbot Faces International Backlash for Antisemitic Content
Severe Heatwave Claims 2,300 Lives Across Europe
NVIDIA Achieves Historic Milestone as First Company Valued at $4 Trillion
Declining Beer Consumption Signals Cultural Shift in Germany
Linda Yaccarino Steps Down as CEO of X After Two Years
US Imposes New Tariffs on Brazilian Exports Amid Political Tensions
Azerbaijan and Armenia are on the brink of a historic peace deal.
Emails Leaked: How Passenger Luggage Became a Side Income for Airport Workers
Polish MEP: “Dear Leftists - China is laughing at you, Russia is laughing, India is laughing”
BRICS Expands Membership with Indonesia and Ten New Partner Countries
Weinstein Victim’s Lawyer Says MeToo Movement Still Strong
×